Goldman Sachs’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-741,548
| Closed | -$949K | – | 4933 |
|
|
2024
Q2 | $949K | Buy |
741,548
+287,315
| +63% | +$368K | ﹤0.01% | 3604 |
|
|
2024
Q1 | $1.31M | Sell |
454,233
-2,826
| -0.6% | -$8.17K | ﹤0.01% | 3453 |
|
|
2023
Q4 | $3.36M | Sell |
457,059
-25,871
| -5% | -$190K | ﹤0.01% | 2867 |
|
|
2023
Q3 | $3.71M | Sell |
482,930
-5,933
| -1% | -$45.6K | ﹤0.01% | 2691 |
|
|
2023
Q2 | $4.96M | Buy |
488,863
+462,652
| +1,765% | +$4.69M | ﹤0.01% | 2576 |
|
|
2023
Q1 | $255K | Buy |
26,211
+15,934
| +155% | +$155K | ﹤0.01% | 4418 |
|
|
2022
Q4 | $49.8K | Sell |
10,277
-1,551
| -13% | -$7.52K | ﹤0.01% | 4791 |
|
|
2022
Q3 | $169K | Sell |
11,828
-6,756
| -36% | -$96.5K | ﹤0.01% | 4772 |
|
|
2022
Q2 | $101K | Buy |
18,584
+3,528
| +23% | +$19.2K | ﹤0.01% | 5117 |
|
|
2022
Q1 | $97K | Buy |
15,056
+1,894
| +14% | +$12.2K | ﹤0.01% | 5324 |
|
|
2021
Q4 | $213K | Buy |
+13,162
| New | +$213K | ﹤0.01% | 4963 |
|